MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Cancer · 2014 · PMC4164022 · PMID 24615748

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

BACKGROUND Mucositis is a highly significant, and sometimes dose‐limiting, toxicity of cancer therapy.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.